Magns Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Pakistan
Pakistan pharmaceutical manufacturer with current DRAP-reviewed product registrations and Drug Manufacturing Licence 000849.
Magns Pharmaceuticals products in Pakistan
Magns Pharmaceuticals has 30 medicine presentations registered in Pakistan under 19 brands, covering 18 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Pain & musculoskeletal. Its brands with the most registered strengths and packs are Magns (Omeprazole), Cflox (Ciprofloxacin), Clithrocin (Clarithromycin) and Zaracin (Azithromycin). 30 products have an official DRAP price on MedInfoBase. See all 19 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 38%
Company location
No exact premises location is published without a defensible source.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Magns Pharmaceuticals is priced against the market
23 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aleze | Loratadine | 10 mg | Tablet | 10,s | 096663 | PKR 133.19 | PKR 13.32/tablet | 🔒 Pharma Pro |
| Cflox | Ciprofloxacin | 250 mg | Tablet | 10,s | 084114 | PKR 247.08 | PKR 24.71/tablet | 🔒 Pharma Pro |
| Cflox | Ciprofloxacin | 500 mg | Tablet | 10,s | 084115 | PKR 408.64 | PKR 40.86/tablet | 🔒 Pharma Pro |
| Cflox | Ciprofloxacin | 250 mg/5 mL | Powder for oral suspension | 1,s (60 ml) | 094603 | PKR 296.00 | — | No comparator |
| Clithrocin | Clarithromycin | 125 mg/5 mL | Powder for oral suspension | 1,s (60 ml) | 084142 | PKR 423.85 | — | No comparator |
| Clithrocin | Clarithromycin | 250 mg | Tablet | 10,s | 095672 | PKR 444.01 | PKR 44.40/tablet | 🔒 Pharma Pro |
| Clithrocin | Clarithromycin | 500 mg | Tablet | 10,s | 095673 | PKR 740.02 | PKR 74.00/tablet | 🔒 Pharma Pro |
| Clithrocin DS | Clarithromycin | 250 mg/5 mL | Powder for oral suspension | 1,s (60 ml) | 084143 | PKR 701.39 | — | No comparator |
| Cytolog | Misoprostol | 200 mcg | Tablet | 10,s | 099109 | PKR 184.99 | PKR 18.50/tablet | 🔒 Pharma Pro |
| Dazbec 30mg capsuleRegistry verified | Dexlansoprazole (as dual delayed release pellets) | — | — | — | 117767Official source ↗ | No indexed price | — | — |
| Dazbec 60mg capsuleRegistry verified | Dexlansoprazole (as dual delayed release pellets) | — | — | — | 117768Official source ↗ | No indexed price | — | — |
| Eryzol | Erythromycin ethylsuccinate + Sulfisoxazole acetyl | 200 mg + 600 mg/5 mL | Powder for oral suspension | 1,s (60 ml) | 093674 | PKR 72.14 | — | No comparator |
| Fadep | Fluoxetine | 20 mg | Capsule | 10,s | 099775 | PKR 120.24 | PKR 12.02/capsule | 🔒 Pharma Pro |
| Flumag | Fluconazole | 50 mg/5 mL | Powder for oral suspension | 1,s (35 ml) | 084144 | PKR 399.14 | — | No comparator |
| Gletto | Metformin | 500 mg | Tablet | 50,s | 099112 | PKR 133.37 | PKR 2.67/tablet | 🔒 Pharma Pro |
| Leufex | Levofloxacin | 250 mg | Tablet | 10,s | 084122 | PKR 475.17 | PKR 47.52/tablet | 🔒 Pharma Pro |
| Leufex | Levofloxacin | 500 mg | Tablet | 10,s | 084123 | PKR 790.69 | PKR 79.07/tablet | 🔒 Pharma Pro |
| Lizon | Linezolid | 100 mg/5 mL | Powder for oral suspension | 1,s (60 ml) | 084145 | PKR 665.25 | — | No comparator |
| Maflex | Moxifloxacin | 400 mg | Tablet | 5,s | 084124 | PKR 902.85 | PKR 180.57/tablet | 🔒 Pharma Pro |
| Magns | Omeprazole | 20 mg | Capsule | 14,s | 084132 | PKR 273.69 | PKR 19.55/capsule | 🔒 Pharma Pro |
| Magns | Omeprazole | 20 mg | Enteric-coated tablet | 10,s | 084132 | PKR 195.75 | PKR 19.58/tablet | 🔒 Pharma Pro |
| Magns | Omeprazole | 20 mg | Enteric-coated tablet | 100,s | 084132 | PKR 1,429.20 | PKR 14.29/tablet | 🔒 Pharma Pro |
| Magns | Omeprazole | 40 mg | Capsule | 14,s | 084133 | PKR 475.16 | PKR 33.94/capsule | 🔒 Pharma Pro |
| Magns 40mg Injection IVRegistry verified | Omeprazole (as Sodium) | — | — | — | 105665Official source ↗ | No indexed price | — | — |
| Magra 100mg TabletRegistry verified | Sildenafil (As Citrate) | — | — | — | 135588Official source ↗ | No indexed price | — | — |
| Magra 25mg tabletRegistry verified | Sildenafil Citrate eq. to Sildenafil | — | — | — | 135589Official source ↗ | No indexed price | — | — |
| Magra 50mg TabletRegistry verified | Sildenafil Citrate eq. to Sildenafil | — | — | — | 135590Official source ↗ | No indexed price | — | — |
| Magsum 1gm InjectionRegistry verified | Cefoperazone as Sodium + Sulbactam as Sodium | — | — | — | 132167Official source ↗ | No indexed price | — | — |
| Magsum 2gm InjectionRegistry verified | Cefoperazone as Sodium + Sulbactam as Sodium | — | — | — | 131168Official source ↗ | No indexed price | — | — |
| Magxone Injection 1g/Vial IVRegistry verified | Ceftriaxone (as sodium) | — | — | — | 105664Official source ↗ | No indexed price | — | — |
| Magxone Injection 250mg/Vial IMRegistry verified | Ceftriaxone (as sodium) | — | — | — | 105662Official source ↗ | No indexed price | — | — |
| Magxone Injection 500mg/Vial IMRegistry verified | Ceftriaxone (as sodium) | — | — | — | 105663Official source ↗ | No indexed price | — | — |
| Magzidol | Paracetamol | 500 mg | Tablet | 200,s | 115656 | PKR 589.32 | PKR 2.95/tablet | 🔒 Pharma Pro |
| Magzidol | Paracetamol | 500 mg | Tablet | 10x10's | 136613 | PKR 332.00 | PKR 3.32/tablet | 🔒 Pharma Pro |
| Penmer 1g InjectionRegistry verified | Meropenem as Trihydrate | — | — | — | 127485Official source ↗ | No indexed price | — | — |
| Penmer 500mg InjectionRegistry verified | Meropenem as Trihydrate | — | — | — | 127484Official source ↗ | No indexed price | — | — |
| Smag | Amlodipine | 5 mg | Tablet | 20,s | 103393 | PKR 166.48 | PKR 8.32/tablet | 🔒 Pharma Pro |
| Trozet | Letrozole | 2.5 mg | Tablet | 30,s | 089934 | PKR 11,100.62 | PKR 370.02/tablet | 🔒 Pharma Pro |
| Vibecin | Doxycycline | 100 mg | Capsule | 100,s | 084139 | PKR 741.28 | PKR 7.41/capsule | 🔒 Pharma Pro |
| Zaracin | Azithromycin | 250 mg | Capsule | 6,s | 084141 | PKR 290.80 | PKR 48.47/capsule | 🔒 Pharma Pro |
| Zaracin | Azithromycin | 250 mg | Capsule | 10,s | 084141 | PKR 484.65 | PKR 48.47/capsule | 🔒 Pharma Pro |
| Zaracin | Azithromycin | 200 mg/5 mL | Powder for oral suspension | 1,s (15 ml) | 086433 | PKR 313.59 | — | No comparator |
| Zilos | Losartan | 50 mg | Tablet | 20,s | 099111 | PKR 370.02 | PKR 18.50/tablet | 🔒 Pharma Pro |
All 19 Magns Pharmaceuticals brands in Pakistan
- Aleze Loratadine · 10 mg tablet
- Cflox Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
- Clithrocin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Clithrocin DS Clarithromycin · 250 mg/5 mL suspension
- Cytolog Misoprostol · 200 mcg tablet
- Eryzol Erythromycin ethylsuccinate + Sulfisoxazole acetyl · 200 mg + 600 mg/5 mL suspension
- Fadep Fluoxetine · 20 mg capsule
- Flumag Fluconazole · 50 mg/5 mL suspension
- Gletto Metformin · 500 mg tablet
- Leufex Levofloxacin · 250 mg tablet, 500 mg tablet
- Lizon Linezolid · 100 mg/5 mL suspension
- Maflex Moxifloxacin · 400 mg tablet
- Magns Omeprazole · 20 mg capsule, 20 mg tablet, 40 mg capsule
- Magzidol Paracetamol · 500 mg tablet
- Smag Amlodipine · 5 mg tablet
- Trozet Letrozole · 2.5 mg tablet
- Vibecin Doxycycline · 100 mg capsule
- Zaracin Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
- Zilos Losartan · 50 mg tablet
Magns Pharmaceuticals: common questions
How many products does Magns Pharmaceuticals have in Pakistan?
Magns Pharmaceuticals has 30 registered medicine presentations in Pakistan, sold under 19 brands and covering 18 generic medicines.
What are the main brands of Magns Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Magns (Omeprazole), Cflox (Ciprofloxacin), Clithrocin (Clarithromycin), Zaracin (Azithromycin) and Leufex (Levofloxacin). This is not a sales ranking.
Which therapy areas does Magns Pharmaceuticals cover?
The most products are in Anti-infectives (17), Gastrointestinal & hepatology (4), Pain & musculoskeletal (2), Cardiovascular (2) and Respiratory & allergy (1).
Where can I see Magns Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.